Preventing Maternal Mood, Anxiety, and Trauma Symptoms After Cesarean Delivery
Launched by UNIVERSITY OF COLORADO, DENVER · Apr 21, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping pregnant women who are at high risk for anxiety, mood disorders, and trauma symptoms, especially after having a cesarean delivery (C-section). Researchers have developed a 1-hour program that includes education about anxiety and a brief introduction to what happens in the operating room during a C-section. The goal is to prevent mental health issues by preparing these women for the experience, rather than just treating problems after they occur. Before a larger trial can begin, the researchers want to refine this program by getting feedback from patients, healthcare providers, and community partners.
To be eligible for this study, participants need to be pregnant women between 22 and 37 weeks along, who are having a high-risk pregnancy and will likely require a C-section at the University of Colorado. They should also be admitted to the hospital for at least three days before the delivery. Participants can expect to take part in this short educational session aimed at reducing anxiety and improving their experience. The study is still in the planning stages and is not yet recruiting participants.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant Patients at 22-37 weeks gestation
- • Single or multiple gestation
- • Nulliparous or multiparous (with prior vaginal or cesarean delivery)
- • Antepartum admission for at least 3 days
- • High-risk pregnancy due to maternal/fetal comorbidities
- • Anticipated cesarean delivery at the University of Colorado
- Exclusion Criteria:
- • Lack of capacity to consent
- • Medical factors prohibiting participation in the intervention as determined by the inpatient obstetric medical team.
- • Anticipated cesarean within 7 days of enrollment
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported